Net profit of Shukra Pharmaceuticals rose 340.74% to Rs 2.38 crore in the quarter ended September 2025 as against Rs 0.54 crore during the previous quarter ended September 2024. Sales rose 5.76% to Rs 5.88 crore in the quarter ended September 2025 as against Rs 5.56 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.885.56 6 OPM %-6.9712.05 - PBDT1.011.58 -36 PBT0.200.88 -77 NP2.380.54 341 Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 1 November 2025.Powered by Capital Market - Live News

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 October 2025.Powered by Capital Market - Live News

Shukra Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News